Subscribe
Sign In
Tag: CBT > CBD FDA: Page 5
Finance
FDA Warns of CBD Use and Marketing, Companies Respond
The FDA recently published a consumer notice regarding CBD’s unknown health effects and sent warning letters to companies allegedly marketing products illegally. Some have responded.
December 4, 2019
Legislation and Regulation
FDA Warns 15 Companies for Illegally Selling CBD Products
The violations include marketing unapproved new human and animal drugs, selling the products as dietary supplements, and adding CBD to human and animal foods.
November 26, 2019
Interviews & Opinion
AmourCBD Secures FDA Registration to Earn Customer Trust
The company has registered its CBD topical cream with the FDA to differentiate itself in the crowded marketplace.
November 7, 2019
Legislation and Regulation
U.S. Hemp Authority Releases Guidance Procedures 2.0
The updated guidance is based on a collaborative industry effort, including more than 2,000 public comments.
November 5, 2019
Legislation and Regulation
Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access
This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.
October 25, 2019
International
Dr. Mechoulam Does It Again
In an exciting mainstream media report, NBC news highlighted a groundbreaking new development from the lab of Dr. Raphael Mechoulam, the godfather of cannabis chemistry: cannabinoid acids.
September 27, 2019
Compliance
Hawaii Health Officials Pull CBD Products Following First Vaping-Related Lung Illness
The question of regulated and unregulated CBD products has vexed state and federal officials for at least the past year.
September 17, 2019
2018 Farm Bill Status
How Far Has CBD Come Since the Passage of the 2018 Farm Bill?
From the FDA’s first-ever hearing on CBD to major retail chains carrying infused products, here is a summary of how hemp and CBD have progressed since federal legalization.
August 8, 2019
Legislation and Regulation
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Curaleaf Holdings, Inc.
Bragar Eagel & Squire encourages curaleaf investors to contact the firm.
August 6, 2019
Legislation and Regulation
Curaleaf Retracts CBD Health Claims After FDA Warning, New York Decriminalizes Cannabis: Week in Review
Curaleaf has scrubbed its website and social media accounts of health claims about its CBD products in response to a warning from the Food and Drug Administration.
August 3, 2019
Legislation and Regulation
Rep. Antonio Delgado Authors Letter with House Small Business Committee Members Supporting Economic Opportunities From CBD in Farming and Small Business
The letter urges the FDA to provide regulatory guidance on CBD products to support American farmers and entrepreneurs in this growing market.
August 2, 2019
Compliance
Curaleaf Scrubs CBD Health Claims From Its Pages in Response to FDA Warning
Curaleaf “immediately began an extensive review of its website and social media platforms to remove all statements that FDA identified as non-compliant.”
July 29, 2019
Previous Page
Page 5 of 6
Next Page
